These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 34254524)

  • 1. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.
    Kim SY; Kim JH; Kim TY; Park SR; Yoon S; Lee S; Lee SH; Kim TM; Han SW; Kim HR; Yun H; Lee S; Kim J; Choi YL; Choi KS; Chae H; Ryu H; Lee GW; Zang DY; Ahn JB
    BMC Cancer; 2024 May; 24(1):574. PubMed ID: 38724991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection.
    Kou T; Kanai M; Kamada M; Nakatsui M; Matsumoto S; Okuno Y; Muto M
    Methods Mol Biol; 2018; 1825():413-424. PubMed ID: 30334215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
    Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
    Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiling in oncology clinical practice.
    Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
    Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy.
    von Baumgarten L; Kumbrink J; Jung A; Reischer A; Flach M; Liebmann S; Metzeler KH; Holch JW; Niyazi M; Thon N; Straube A; von Bergwelt-Baildon M; Heinemann V; Kirchner T; Westphalen CB
    Theranostics; 2020; 10(2):856-866. PubMed ID: 31903155
    [No Abstract]   [Full Text] [Related]  

  • 9. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
    Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
    Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Oncology: Who, How, What, When, and When Not?
    Schwartzberg L; Kim ES; Liu D; Schrag D
    Am Soc Clin Oncol Educ Book; 2017; 37():160-169. PubMed ID: 28561651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possibility of clinical sequencing in the management of cancer.
    Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
    Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genomic profiling for oncological advancements by precision medicine.
    Pankiw M; Brezden-Masley C; Charames GS
    Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
    Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
    Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences.
    Tóth E; Kürönya Z; Soós E; Pintér T; Butz H; Horváth Z; Csernák E; Grolmusz VK; Székely J; Straussz T; Lövey J; Jánvári L; Báthory-Fülöp L; Nagy P; Polgár C; Patócs A
    Acta Oncol; 2024 Jun; 63():433-440. PubMed ID: 38881341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
    Mosele MF; Westphalen CB; Stenzinger A; Barlesi F; Bayle A; Bièche I; Bonastre J; Castro E; Dienstmann R; Krämer A; Czarnecka AM; Meric-Bernstam F; Michiels S; Miller R; Normanno N; Reis-Filho J; Remon J; Robson M; Rouleau E; Scarpa A; Serrano C; Mateo J; André F
    Ann Oncol; 2024 Jul; 35(7):588-606. PubMed ID: 38834388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.
    Sabari JK; Santini F; Bergagnini I; Lai WV; Arbour KC; Drilon A
    Curr Oncol Rep; 2017 Apr; 19(4):24. PubMed ID: 28303491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging roles of NGS in clinical oncology and personalized medicine.
    Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
    Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
    Lih CJ; Takebe N
    Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.